Miyazaki, Ryosuke
Sakurai, Toshiyuki
Shimada, Mariko
Iwashita, Yuko
Shibuya, Naoki
Akita, Yoshihiro
Miyashita, Haruna
Maruyama, Yuki
Saruta, Masayuki
Article History
Received: 8 March 2022
Accepted: 16 June 2022
First Online: 24 June 2022
Change Date: 25 August 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12876-022-02445-0
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and ethical guidelines issued from administrative departments, and was approved by the Local Ethics Committee of The Jikei University School of Medicine (No. 32–2729771) and carried out by the opt out consent process. Written informed consent was waived by the ethics committee.
: M. Saruta has received consulting and lecture fees from Abbvie GK., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd, EA Pharma Co., Ltd., and Gilead K.K; and research grants from EA Pharma Co., Ltd., EP-CRSU Co., Ltd., Mitsubishi Tanabe Pharma, Mochida Pharmaceutical Co., Ltd., and Zeria Pharmaceutical Co., Ltd. The other authors have no conflicts of interest related to this article.
: Not applicable.